The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 59, Issue 12, 2010, Pages 1816-1822

  Osonoi, Takeshi ^a   Saito, Miyoko ^a   Mochizuki, Kazuki ^b   Fukaya, Nanae ^b   Muramatsu, Takeshi ^b   Inoue, Seiya ^b   Fuchigami, Masahiro ^c   Goda, Toshinao ^b  

^a Naka Memorial Clinic   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

^c SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; C REACTIVE PROTEIN; CALGRANULIN A; CALVASCULIN; CHOLESTEROL; GAMMA INTERFERON; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; MIGLITOL; PROTEIN S 100; PROTEIN S 100A10; PROTEIN S 100A11; PROTEIN S 100A12; PROTEIN S 100A6; PROTEIN S 100A9; RNA 18S; SULFONYLUREA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VOGLIBOSE;

ABDOMINAL DISTENSION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FLATULENCE; GENE EXPRESSION; HUMAN; HYPOGLYCEMIA; INTESTINE FUNCTION DISORDER; JAPANESE; LEUKOCYTE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 78549280114     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.06.006     Document Type: Article

References (35)

1. Schmidt D.D., Frommer W., Junge B., and Muller L. α-Glucosidase inhibitors. New complex oligosaccharides of microbial origin Naturwissenschaften 64 1977 535 536
2. Caspary W.F., and Graf S. Inhibition of human intestinal α-glucosidehydrolases by a new complex oligosaccharide Res Exp Med (Berl) 175 1979 1 6
3. Puls W., Keup U., Krause H.P., and Muller L. Pharmacology of α glucosidase inhibitor Front Hormone Res 7 1980 235 247
4. Goda T., Yamada K., Hosoya N., and Moriuchi S. Effects of α-glucosidase inhibitor BAY g 5421 on rat intestinal disaccharidases J Jpn Soc Nutr Food Sci 34 1981 139 143
5. Horii S. Valiolamine and its N-substituted derivatives, α-d-glucosidase inhibitors: from validamycins to voglibose (AO-128), an antidiabetic agent J. Takeda Res. Lab 52 1993 1 26
6. Azuma K., Toyofuku Y., Iesaki T., and Otsuka A. Acarbose, an α-glucosidase inhibitor, improves endothelial dysfunction in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation Biochem Biophys Res Commun 345 2006 688 693 (Pubitemid 43776986)
7. Koyama M., Wada R., Mizukami H., and Sakuraba H. Inhibition of progressive reduction of islet β-cell mass in spontaneously diabetic Goto-Kakizaki rats by α-glucosidase inhibitor Metabolism 49 2000 347 352
8. Liao Y., Takashima S., Zhao H., and Asano Y. Control of plasma glucose with α-glucosidase inhibitor attenuates oxidative stress and slows the progression of heart failure in mice Cardiovasc Res 70 2006 107 116
9. Giugliano D., Ceriello A., and Esposito K. Glucose metabolism and hyperglycemia Am J Clin Nutr 87 2008 217S 222S
10. Chiasson J.L., Josse R.G., Gomis R., and Hanefeld M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial Lancet 359 2002 2072 2077
11. Chiasson J.L., Josse R.G., Gomis R., and Hanefeld M. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial JAMA 290 2003 486 494
12. Zeymer U., Schwarzmaier-D'assie A., Petzinna D., and Chiasson J.L. Effect of acarbose treatment on the risk of silent myocardial infarctions in patients with impaired glucose tolerance: results of the randomised STOP-NIDDM trial electrocardiography substudy Eur J Cardiovasc Prev Rehabil 11 2004 412 415
13. Hanefeld M., Cagatay M., Petrowitsch T., and Neuser D. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies Eur Heart J 25 2004 10 16
14. Puls W., Krause H.P., Muller L., and Schutt H. Inhibitors of the rate of carbohydrate and lipid absorption by the intestine Int J Obes 8 Suppl 1 1984 181 190
15. Samulitis B.K., Goda T., Lee S.M., and Koldovsky O. Inhibitory mechanism of acarbose and 1-deoxynojirimycin derivatives on carbohydrases in rat small intestine Drugs Exp Clin Res 13 1987 517 524
16. Goda T., Suruga K., Komori A., and Kuranuki S. Effects of miglitol, an α-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats Br J Nutr 98 2007 702 710
17. Mita T., Otsuka A., Azuma K., and Uchida T. Swings in blood glucose levels accelerate atherogenesis in apolipoprotein E-deficient mice Biochem Biophys Res Commun 358 2007 679 685
18. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance J Clin Invest 116 2006 1793 1801
19. Lu L., Zhang Q., Pu L.J., and Xu X.W. Elevation of tumor necrosis factor-α, interleukin-1β and interleukin-6 levels in aortic intima of Chinese Guizhou minipigs with streptozotocin-induced diabetes Chin Med J (Engl) 120 2007 479 484
20. Wen Y., Gu J., Li S.L., and Reddy M.A. Elevated glucose and diabetes promote interleukin-12 cytokine gene expression in mouse macrophages Endocrinology 147 2006 2518 2525
21. Foell D., Frosch M., Sorg C., and Roth J. Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation Clin Chim Acta 344 2004 37 51
22. Bouma G., Lam-Tse W.K., Wierenga-Wolf A.F., and Drexhage H.A. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin Diabetes 53 2004 1979 1986
23. Kosaki A., Hasegawa T., Kimura T., and Iida K. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes J Clin Endocrinol Metab 89 2004 5423 5428
24. Ehlermann P., Eggers K., Bierhaus A., and Most P. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products Cardiovasc Diabetol 5 2006 6
25. Arakawa M., Ebato C., Mita T., and Fujitani Y. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects Metabolism 57 2008 1299 1306
26. Fukaya N., Mochizuki K., Shimada M., and Goda T. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes Nutrition 25 2009 657 667
27. Tanaka Y., Mochizuki K., Fukaya N., and Shimada M. The α-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1β and tumour necrosis factor-α gene expression in rat peripheral leucocytes induced by intermittent sucrose loading Br J Nutr 102 2009 221 225
28. Schlichtkrull J., Munck O., and Jersild M. M-value, an index for blood sugar control in diabetics Ugeskr Laeger 126 1964 815 820
29. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 2001 402 408
30. Spranger J., Kroke A., Mohlig M., and Hoffmann K. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study Diabetes 52 2003 812 817
31. Kim E.S., Im J.A., Kim K.C., and Park J.H. Improved insulin sensitivity and adiponectin level after exercise training in obese Korean youth Obesity (Silver Spring) 15 2007 3023 3030
32. Bruun J.M., Stallknecht B., Helge J.W., and Richelsen B. Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss Eur J Endocrinol 157 2007 465 471
33. Gebhardt C., Nemeth J., Angel P., and Hess J. S100A8 and S100A9 in inflammation and cancer Biochem Pharmacol 72 2006 1622 1631
34. Basta G., Sironi A.M., Lazzerini G., and Del Turco S. Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein J Clin Endocrinol Metab 91 2006 4628 4634
35. Lachmann H.J., Lowe P., Felix S.D., and Rordorf C. In vivo regulation of interleukin 1β in patients with cryopyrin-associated periodic syndromes J Exp Med 206 2009 1029 1036